Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Y Dirix

Showing results (21-30 of 108) with videos related to

Pageof 11
Sort By:
Cancer|August 15, 1991
Alpha-interferon (IFN) in the treatment of metastatic carcinoid tumorsL Y Dirix, A M Prove, H Fierens, et al.
British Journal of Cancer|November 1, 1996
High endothelial cell proliferation index and high microvessel density in vascular hotspots suggest an active angiogenic process in human colorectal adenocarcinomas. Angiogenesis GroupP B Vermeulen, L Y Dirix, E Van Marck, et al.
Therapeutic Advances in Medical Oncology|July 27, 2011
Bevacizumab in the treatment of patients with advanced breast cancer: where have we landed?L Y Dirix, P A Van Dam, A M Prove, et al.
Acta Clinica Belgica|January 1, 1988
Radiation related malignant fibrous histiocytomaL Y Dirix, H Fierens, G Langerock, et al.
Histopathology|March 21, 2002
Lack of angiogenesis in lymph node metastases of carcinomas is growth pattern-dependentP B Vermeulen, P Sardari Nia, C Colpaert, et al.
Journal of the National Cancer Institute|September 18, 1997
Serum basic fibroblast growth factor and vascular endothelial growth factor in metastatic renal cell carcinoma treated with interferon alfa-2bP B Vermeulen, L Y Dirix, M Martin, et al.
Cancer|April 15, 1991
Tumor lysis syndrome in a patient with metastatic Merkel cell carcinomaL Y Dirix, A Prove, D Becquart, et al.
European Journal of Cancer (Oxford, England : 1990)|September 3, 2002
Heterogeneity of vascularisation in invasive breast carcinomaP B Vermeulen, S B Fox, L Y Dirix, et al.
Urologia Internationalis|January 1, 1995
Cryptorchidism and extragonadal germ cell tumorL Y Dirix, E Wouters, J Van Nueten, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Compassionate use of tropisetron in patients at high risk of severe emesisH Bleiberg, S Van Belle, R Paridaens, et al.
Pageof 11

Showing results (21-30 of 108) with videos related to

Sort By:
Pageof 11
Cancer|August 15, 1991
Alpha-interferon (IFN) in the treatment of metastatic carcinoid tumorsL Y Dirix, A M Prove, H Fierens, et al.
British Journal of Cancer|November 1, 1996
High endothelial cell proliferation index and high microvessel density in vascular hotspots suggest an active angiogenic process in human colorectal adenocarcinomas. Angiogenesis GroupP B Vermeulen, L Y Dirix, E Van Marck, et al.
Therapeutic Advances in Medical Oncology|July 27, 2011
Bevacizumab in the treatment of patients with advanced breast cancer: where have we landed?L Y Dirix, P A Van Dam, A M Prove, et al.
Acta Clinica Belgica|January 1, 1988
Radiation related malignant fibrous histiocytomaL Y Dirix, H Fierens, G Langerock, et al.
Histopathology|March 21, 2002
Lack of angiogenesis in lymph node metastases of carcinomas is growth pattern-dependentP B Vermeulen, P Sardari Nia, C Colpaert, et al.
Journal of the National Cancer Institute|September 18, 1997
Serum basic fibroblast growth factor and vascular endothelial growth factor in metastatic renal cell carcinoma treated with interferon alfa-2bP B Vermeulen, L Y Dirix, M Martin, et al.
Cancer|April 15, 1991
Tumor lysis syndrome in a patient with metastatic Merkel cell carcinomaL Y Dirix, A Prove, D Becquart, et al.
European Journal of Cancer (Oxford, England : 1990)|September 3, 2002
Heterogeneity of vascularisation in invasive breast carcinomaP B Vermeulen, S B Fox, L Y Dirix, et al.
Urologia Internationalis|January 1, 1995
Cryptorchidism and extragonadal germ cell tumorL Y Dirix, E Wouters, J Van Nueten, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Compassionate use of tropisetron in patients at high risk of severe emesisH Bleiberg, S Van Belle, R Paridaens, et al.
Pageof 11